Haw ParHAWPF 95 OCF Margin % is 28.87% as of Dec. 2025, which is 11% above its 10-year median of 25.93. GuruFocus rates HAWPF with a GF Score™ of 95/100 and a GF Value™ of $8.79. The stock has 3 warning signs investors should review. Among 959 Drug Manufacturers companies, Haw Par ranks better than 86.44% on this metric.
The historical rank and industry rank for Haw Par's OCF Margin % or its related term are showing as below:
HAWPF'
s OCF Margin % Range Over the Past 10 Years
Min: 13.35 Med: 25.93 Max: 45.4
Current: 24.83
During the past 13 years, the highest OCF Margin % of Haw Par was 45.40%. The lowest was 13.35%. And the median was 25.93%.
HAWPF's OCF Margin % is ranked better than 86.44% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs HAWPF: 24.83
Haw Par OCF Margin % Related Terms
Haw Par OCF Margin % Historical Data
* Premium members only.
The historical data trend for Haw Par's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Haw Par's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haw Par OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Haw Par's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Haw Par's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haw Par (HAWPF) has a OCF Margin % of 28.87% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Haw Par and its competitors. This is 11% above median its historical median of 25.93. Over the past decade, Haw Par's OCF Margin % has ranged from 13.35 to 45.40. According to the industry distribution chart, Haw Par ranks #130 out of 959 companies in the Drug Manufacturers industry, placing it in the top 13.6%.
Is Haw Par's OCF Margin % too high?
Haw Par's current OCF Margin % of 28.87% is 11% above median its 10-year median of 25.93. Over the past 10 years, this metric has ranged from a low of 13.35 to a high of 45.40. The Drug Manufacturers industry median OCF Margin % is 9.95. Haw Par's value of 28.87% is 190.2% above this industry median. Based on the distribution chart, Haw Par ranks #130 out of 959 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Haw Par has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does Haw Par's OCF Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Haw Par ranks #130 out of 959 companies for OCF Margin %. This places Haw Par in the top 14% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.95. Haw Par's value of 28.87% is 190.2% above this benchmark. Historically, Haw Par's own OCF Margin % has ranged from 13.35 to 45.40 over the past decade. While the company's 10-year median is 25.93 vs. the industry median of 9.95, Haw Par has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Haw Par's current OCF Margin % of 28.87% is 190.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Haw Par and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haw Par's current OCF Margin % is 28.87%, which is 11% above median its own 10-year median of 25.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haw Par stock overvalued right now?
Haw Par (HAWPF) has a current OCF Margin % of 28.87%. The stock's GF Value™ is $8.79, compared to a current price of $12.00 — trading 36.5% above its estimated fair value. The current OCF Margin % is 28.87%, which is 11% above median its 10-year median of 25.93 and 190.2% above the Drug Manufacturers industry median of 9.95. Haw Par's overall GF Score™ is 95/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Haw Par (HAWPF), the current OCF Margin % is 28.87% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Haw Par (HAWPF) Overvalued in 2026?
Based on GuruFocus' analysis, Haw Par stock appears to be overvalued.
The current stock price of $12.00 is trading 36.5% above its estimated GF Value™ of $8.79.
Key valuation signals for HAWPF:
OCF Margin %: 28.87% (11% above median its 10-year median of 25.93)
GF Value™: $8.79 vs. price of $12.00 (36.5% above fair value)
Industry Position: 190.2% above the Drug Manufacturers median (#130 of 959)
No single metric tells the full story. See the HAWPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, Property segment, and Leisure segment. The company generates the majority of its revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates key revenue from the other ASEAN and other Asian countries.
95GF Score
Get the complete analysis for HAWPF
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAWPF has been successfully added to your 
